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An investigation into utilising gestational body mass index 
as a screening tool for adverse birth outcomes and maternal 
morbidities in a group of pregnant women in Khayelitsha
Introduction 
Maternal and child health has been one of the top health priorities 
in South Africa since the African National Congress came into power 
in 1994 and the Millennium Development Goals were agreed and 
implemented by the United Nations in 2000 (using 1990 figures).1 
Despite some progress, maternal and child mortality rates are still 
unacceptably high in South Africa.1 A mother’s nutritional status 
is one of the most important determinants of maternal and birth 
outcomes.2,3 There are several methods of measuring nutritional 
status during pregnancy, although a universal method has not been 
accepted.4 This has led to different methods being used in different 
studies, and could explain some of the conflicting reported results.4 
The Institute of Medicine method is similar to the majority of these 
methods which require the pregravid weight and body mass index 
(BMI) of a pregnant woman, and for her to be weighed at regular 
antenatal clinic appointments.5 Attendance at antenatal clinics has 
increased in South Africa by 25% since 1994, mainly because of the 
implementation of basic free health care for pregnant women and 
children below the age of six.6 The mean number of antenatal visits 
in South Africa was 3.8 in 2003. The Western Cape had the highest 
continuous attendance of 4.9.6,7 Nevertheless, the reality is that in a 
peri-urban township setting many women attend these clinics later 
on in their pregnancy (a mean of 5.5 months).6 Therefore, pregravid 
weight and BMI are not always measured or known, thus impacting 
on the calculation method recommended by the IOM.  
The Argentinian Ministry of Health developed a logarithmic equation 
to adjust maternal BMI for gestational age using an adaptation of 
the Epi Info® nutrition software programme.8 Using this software, 
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Objective: The aim of this study was to investigate the ability of the gestational body mass index (BMI) method to screen for adverse birth 
outcomes and maternal morbidities.  
Design: This was a substudy of a randomised controlled trial, the Philani Mentor Mothers’ study.
Setting and subjects: The Philani Mentor Mothers’ study took place in a peri-urban settlement, Khayelitsha, between 2009 and 2010. 
Pregnant women living in the area in 2009-2010 were recruited for the study.
Outcome measures: Maternal anthropometry (height and weight) and gestational weeks were obtained at baseline to calculate the gestational 
BMI, which is maternal BMI adjusted for gestational age. Participants were classified into four gestational BMI categories: underweight, 
normal, overweight and obese. Birth outcomes and maternal morbidities were obtained from clinic cards after the births.  
Results: Pregnant women were recruited into the study (n = 1 058). Significant differences were found between the different gestational 
BMI categories and the following birth outcomes: maternal (p-value = 0.019) infant hospital stay (p-value = 0.03), infants staying for over 24 
hours in hospital (p-value = 0.001), delivery mode (p-value = 0.001), birthweight (p-value = 0.006), birth length (p-value = 0.007), birth head 
circumference (p-value = 0.007) and pregnancy-induced hypertension (p-value = 0.001).  
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tool is evaluated. Appropriate medical and nutritional advice can then be given to pregnant women to improve both their own and their infants’ 
birth-related outcomes and maternal morbidities. 
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the calculated gestational BMI can be grouped into categories.8 
Subsequently Cruz et al9 utilised this equation, together with specific 
biochemical parameters.9 They investigated the BMI of human 
immunodeficiency virus (HIV)- positive South American pregnant 
women and birth outcomes (n = 697).9 The main findings were 
similar to those of studies which observed accumulative weight gain 
and birth outcomes, namely those in which underweight women gave 
birth to infants of lower weight, shorter length and with a smaller 
head circumference (HC), compared to infants born to mothers in the 
normal or overweight category.9,10 This method does not depend on 
the timing of the antenatal visit as it adjusts for gestational age.8,9 
Therefore, it could be used as an alternative method with which to 
screen for adverse birth outcomes and maternal morbidity in a South 
African peri-urban setting. 
There is no consensus as to which method is the most appropriate 
when screening for birth outcomes and maternal morbidity. Risk 
factors need to be identified and managed accordingly to prevent 
maternal and infant deaths.6 The establishment and implementation 
of a reliable and uni-occasion screening method is required as public 
health policy. Appropriate medical and nutritional intervention can 
then be given to pregnant woman before, during and after birth to 
improve maternal and birth outcomes. The aim of this study was 
to investigate the ability of the gestational BMI method to identify 
adverse birth outcomes and maternal morbidities in a South African 
peri-urban setting.  
Materials and methods
Participants
The current study used baseline data from participants (n = 1 058) 
in a community-based, cluster-randomised controlled trial, the 
Philani Mentor Mothers’ study.11 The study took place in Khayelitsha, 
Western Cape, between 2009 and 2010. Twenty-four matched 
neighbourhoods [matched according to housing density, type of 
housing (formal or informal), source of public services, length of 
residence and number of shebeens (informal unlicenced bars)] 
were identified in the peri-urban settlement.  Twelve of these were 
randomly assigned to a mentor mother in the intervention (described 
elsewhere),11 while the other 12 were assigned to standard-care 
control. Recruiters knocked on the door of every house in each 
neighbourhood and invited pregnant women in the household 
to participate in the Philani Mentor Mothers’ study. If no one was 
present at the house, the recruiter would return until someone 
was at home to ensure that no pregnant women were missed. All 
participants were given a personal participant identity number (ID).
Participants were included in the Philani Mentor Mothers’ study if the 
following inclusion criteria were met: they were over 18 years of age, 
pregnant, living in the study neighbourhood within Khayelitsha for 
the duration of the study, and were able to provide informed consent.
Ethics
Ethical approval was obtained for the Philani Mentor Mothers’ study 
from the University of California (No G07-02-033) and Stellenbosch 
University (No8/08/218) ethics committees. Each participant signed 
an informed consent form and was given a participant ID to maintain 
participant confidentiality.
Procedure
Participants who were willing to participate in the Philani Mentor 
Mothers’ study were collected from their homes, and taken to the 
data assessment centre in Khayelitsha, Cape Town. Once they had 
signed an informed consent form, trained research assistants carried 
out interviews using population-specific questionnaires (baseline 
questionnaires developed by the research team and translated 
into Xhosa, the predominant spoken language in Khayelitsha).11 
The questionnaires included child health status, health care 
and monitoring, HIV-related preventive acts, mental health and 
social support.11 Information was recorded using mobile phone 
technology.12 Once the interview was uploaded to a central database, 
it was automatically deleted from the mobile phone. The uploaded 
data were reviewed and managed for each entry against written 
folders. The quality of the data for each interview was checked by 
the Philani Mentor Mothers’ study assessment data coordinator. A 
random selection of interviews was cross-checked by an external 
quality controller. Participants were then given a food voucher and 
taken home. They were also given a card with their participant ID and 
the assessment centre phone number. They were asked to contact 
the assessment centre once their babies were born. The assessment 
interviewers went to the participants’ homes two days after the birth 
and carried out the birth questionnaire.  
Anthropometric measurements
Data collectors attended a training workshop held by a registered 
dietitian with International Society of Kinanthropometry accreditation 
on obtaining anthropometric measurements. Maternal weight was 
measured to the nearest 0.1 kg using a calibrated precision health 
scale.13 Maternal height was measured to the nearest 0.01 m using a 
calibrated stationary stadiometer. Duplicates of these measures were 
completed by three data collectors during the baseline questionnaire 
using standardised methods.13
The infant’s birthweight, length and HC were obtained from the clinic 
card which was completed at the maternal obstetric unit. Duplicate 
measures of all three measurements were taken by the data 
collectors during the birth questionnaire. Birthweight was obtained 
by weighing mother and child and subtracting maternal weight. 
Length was measured using a standard length board, and HC was 
obtained using a non-distorting measuring tape.13
Gestational body mass index
Gestational BMI was calculated using the equation for adjusted 
BMI for gestational age, e.g. if pregravid BMI is ≥ 21 to < 25 kg/
m2, then the equation; [(weight - 5.5) ÷ (height2)] = gestational BMI8 
at enrolment. The GBMI is categorised into underweight (≥ 10 to 
≤ 19.8 kg/m2), normal weight (≥ 19.8 to ≤ 26.1 kg/m2), overweight 
(≥ 26.1 to ≤ 29 kg/m2), and obese (≥ 29 to ≤ 50 kg/m2).8,9 
Birth outcomes and adverse events
The participants were asked the following birth outcomes in the birth 
questionnaire: delivery facility, delivery mode, length of maternal 
hospital stay, length of infant hospital stay, the development of 
gestational diabetes or pregnancy-induced hypertension. The 
following birth outcomes were obtained from the infant’s clinic 
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card: gestational age, weight, length and HC. Gestational age was 
classified as preterm ≤ 37 weeks, term ≥ 37 to ≤ 42, and post-term 
42 weeks or more.14 Z-scores were calculated (for this particular 
cohort) for birthweight, length and HC. They were then categorised 
into z-score 1 [≤ - 2 standard deviation (SD)], z-score 2 (≥ - 2 SD, 
≤ + 2 SD) and z-score 3 (≥ + 2 SD).15 Weight was documented as 
low birthweight ≤ 2 500 g and macrosomia  ≥ 4 500 g.16 The Philani 
Mentor Mothers’ study followed-up the participants until the end of 
2011. Therefore, the following occurrences were included and were 
termed as adverse events in this study: miscarriages; stillbirths; 
neonatal, infant or maternal deaths; or termination of pregnancy. 
Data analysis
Microsoft Excel® was used to capture the data and SPSS® (version 
18) to analyse the data. Summary statistics described the variables. 
Medians and quartiles or means and SD were used to describe ordinal 
and continuous responses. A multivariate analysis of variance was 
used to determine if there was a statistical difference between the 
intervention and control groups. If groups were significantly different, 
the results were calculated separately. If there was no significant 
difference, results were calculated using the combined data. The 
association of gestational BMI at enrolment with categorical birth 
outcomes was evaluated using contingency tables and the likelihood 
ratio chi-square test. If cells had a count less than 5%, data were 
transformed using (x + 0.5).17 Randomised block analysis of variance 
was then calculated using this transformed data. Student-Newman-
Keuls post hoc tests were performed to analyse the significant 
difference between categories and outcome groups. P-value < 0.05 
represented statistical significance.
Results
Characteristics of the participants
The baseline characteristics collected during the enrolment of 
1 058 pregnant women participating in the Philani Mentor Mothers’ 
study are shown in Table I. There was a refusal rate of 2% during 
recruitment. Participants had an average age (± SD) of 26 ± 5.4 
years. Most participants (50.8%, n = 537) were in the third trimester. 
Xhosa (99.5%, n = 1 053) was the predominantly spoken language 
among participants.
Few of the participants (3.6%, n = 38) reported that they were 
smokers. Approximately 90% (89.4%, n = 946) of participants had 
IDs. IDs are essential for booking into the antenatal clinics. 78.6% 
(n = 832) had booked in. The majority of births took place in a 
hospital (67.0%, n = 709).
More than half (57.1%, n = 604) of the participants were either 
married or cohabiting, but 88.8% (n = 939) had completed high 
school. Unemployment was high at 80.3% (n = 850). Over half 
(54.5%, n = 580) had a monthly household income of less than 2 000 
South African Rands (US$290). Nearly two thirds of the participants 
(69.6%, n = 736) lived in an informal dwelling, i.e. a wood and iron 
structure which did not meet basic building standards). During their 
current pregnancy, 20.3% (n = 215) and 91.9% (n = 973) had been 
tested for tuberculosis and HIV, respectively. Of those tested, 1.4% 
(n = 3) had tuberculosis and 26.2% (n = 255) were HIV-positive.  
Anthropometry and gestational body mass index 
Anthropometry and calculated gestational BMI scores are detailed in 
Table IIa. Participants had an average height of 1.59 m ± 0.06 and 
a gestational BMI of 27.19 ± 5.83. The highest number in the group 
(44.2%, n = 468) were in the normal gestational BMI category.    
Adverse events
Adverse events were categorised according to gestational BMI 
categories (Table IIb). The most common adverse event were 
miscarriages (2.5%, n = 26), followed by infant deaths (2.3%, n = 
23). Although these occurred predominantly in the normal gestational 
BMI group, no statistical difference was found between the four 
gestational BMI categories and adverse events as the frequency 
counts were too low to analyse.
Table I: Socio-economic and demographic characteristics of the 
participants
n Mean ± 
SD or %
95% CI
Socio-economic and demographic characteristics
Age 1 058 26.3 ± 5.4
Smokers 38 3.6. 2.6-4.9
Identity document available 946 89.4 87.4-91.1
Xhosa-speaking 1 053 99.5 98.9-99.8
Third trimester 537 50.8 47.7-53.8
Booked at antenatal clinic 832 78.6 76.1-81
Planned pregnancies 278 26.3 23.7-29
Babies born in hospital, MOU or 
day clinic
709 67 64.1-69.8
Babies born at home, in their 




Single 454 42.9 40-45.9
Married or cohabiting 604 57.10 54.1-60
Education
Primary 80 7.60 6.1-9.3
Secondary 939 88.8 86.7-90.5
Tertiary 39 3.6 2.7-5
Employment and monthly income
Employed 208 19.7 17.4-22.2
Unemployed 850 80.3 77.8-82.6
> 2 000 South African Rand 478 45.5 42.2-48.2
< 2 000 South African Rand 580 54.5 51.8-57.8
Housing
Formal structure 322 30.4 27.7-33.3
Informal structure 736 69.6 66.7-72.3
Tuberculosis or HIV status
Tuberculosis-positive (of those 
who tested) (20.3%, n = 215)
3 1.4 0.5-4
HIV-positive (of those who tested)  
(91.9%, n = 973)
255 26.2 23.5-29.1
*: otherwise not specified by the mother during the birth questionnaire
CI: confidence interval, HIV: human immunodeficiency virus, MOU: midwife obstetric units, SD: 
standard deviation
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Birth outcomes
Birth outcomes are presented in Table III. No significant difference 
was found between the intervention and control groups. Over three 
quarters (75.5%, n = 799) of the births were vaginal deliveries. Over 
half of the births were term (56.6%, n = 598). Most of the infants 
were in the normal z-score range for birthweight (90.5%, n = 958), 
birth length (82.1%, n = 869) and birth HC (80.2%, n = 849). There 
was a low percentage of low birthweight infants (3.4%, n = 36). 
Ninety (8.5%) infants were macrosomic. Only 2.8% (n = 30) of the 
women developed gestational diabetes mellitus, whereas more 
developed pregnancy-induced hyptertension (17.6%, n = 186).  
A significant difference was found between the gestational BMI 
groups, where the highest prevalence of the following birth outcomes 
was found in the obese group: Caesarean sections (p-value = 0.001) 
and pregnancy-induced hypertension (p-value = 0.001). There was 
a significant difference between the four gestational BMI categories 
and maternal hospital stay (p-value = 0.02). The greatest proportion 
of women who stayed in hospital longer than one day were 
found in the overweight (47.8, n = 86) and obese (56%, n = 196) 
groups. There was a significant difference between the gestational 
BMI categories and the number of babies staying for more than 
24 hours in hospital (p-value = 0.024). The majority of infants born 
to women in the obese gestational BMI category stayed in hospital 
for longer than 24 hours. A significant difference was found between 
the underweight and normal-weight gestational BMI groups, and 
underweight and obese gestational BMI groups, and infants staying 
in hospital for longer than 24 hours (p-value = 0.001). The majority 
of infants from mothers in the underweight, obese and normal 
gestational BMI categories stayed in hospital for ≤ 3 days, ≥ 3 days 
but ≤ 2 weeks, and ≥ 2 weeks, respectively.  
The majority (95.6%, n = 1 012) of women in the Philani Mentor 
Mothers’ study had clinic cards. Of these, 91.1%, 53% and 86.1% 
had their babies’ birthweight, length and HC measured and 
documented, respectively. These measures were repeated when 
the birth questionnaire was undertaken. There was no significant 
difference between results. Therefore, z-scores were calculated for 
both time measures. A significant difference was found between 
birth (values not included in Table III) and current (2-7 days after 
birth) birthweight, length and HC. A significant difference was found 
between the z-score 1 and z-score 2, and z-score 2 and z-score 3, 
for birthweight (p-value = 0.006), length (p-value = 0.01) and HC 
(p-value = 0.01); and post-birth (2-7 days) (p-value = 0.006), length 
(p-value = 0.007) and HC (p-value = 0.007). A significant difference 
was also found between women who developed gestational diabetes 
mellitus and those who did not (p-value = 0.048). Although significant 
differences were found between groups, post hoc tests revealed that 
there was no significant difference between the gestational BMI 
categories.
Discussion
Significant results were reported in this study which linked to 
the ability of the gestational BMI method to identify certain birth 
outcomes and maternal morbidities. No significant difference was 
found between the four gestational BMI categories and adverse 
events, such as stillbirths and miscarriages, as the frequency counts 
were too low to analyse.
South Africa’s Caesarean section rate (16.1%, range 3.2-32.5%) 
was higher than the World Health Organization’s recommended rate 
of 15% in 2008/2009.18,19 The rate in the Western Cape (20.4%) 
was at the upper end of the South African range.19 The Caesarean 
section rate is an important indicator of obstetric care in low-income 
countries.20 Several factors influence this high rate, one of which 
is a high HIV prevalence, although HIV is not a clinical indicator 
for a Caesarean section.20 Caesarean sections impact on the cost 
to the health system and the well-being of the mother and child.19 
Knowledge of the reasons behind these differences in the rates in 
South Africa is required.19 In the present study, women in the obese 
gestational BMI category had significantly more Caesarean sections, 
as have women in other studies.20-22 Only a quarter (24%) of the 
births in the peri-urban settings are performed by a doctor.6 This 
highlights the need for a more accurate way in which to classify at-
risk women, so that high-risk births can be carried out by a doctor 
and more postpartum care given.6
In this study, significantly more mothers and babies who stayed in 
hospital for over 24 hours in were found in the obese gestational 
BMI category. Public hospitals in middle- to low-income countries 
Table IIa: Gestational body mass indices of participants
Anthropometry n of total Mean (± SD) or % 95% CI
Height 1 058 1.59 ± 0.06
Gestational body mass index 27.19 ± 5.83
Underweight 60 5.7 4.4-7.2
Normal 468 44.2 41.3-47.2
Overweight 180 17 14.9-19.4
Obese 350 33.1 30.3-35.9
CI: confidence level, SD: standard deviation






















Underweight 3.8 (1) 4.8 (1) 6.7 (1) 0 (0) 0  (0) 0 (0)
Normal 38.4 (10) 42.8 (9) 20.0 (3) 40 (2) 73.8 (17) 0 (0)
Overweight 26.9 (7) 14.3 (3) 26.7 (4) 20 (1) 13.1 (3) 75 (3)
Obese 30.9 (8) 38.1 (8) 46.6 (7) 40 (2) 13.1 (3) 25 (1)
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Table III: Birth outcomes and maternal morbidities overall and according to gestational body mass index at enrolment
Maternal gestational body mass index (kg/m2) at enrolment
Birth outcome
Overall
% (n of total)
100 (1 058 of 1 058)
Underweight
(≥ 10.0 to ≤ 19.8)
% (n of total)
5.7 (60 of 1 058)
Normal weight 
(≥ 19.8 to ≤ 26.1)
% (n of total)
44.2 (468 of 1 058)
Overweight
(≥ 26.1 to ≤ 29)
% (n of total)
17.1 (180 of 1 058)
Obese 
(≥ 29 to ≤ 50)
% (n of total)
33 (350 of 1 058)
Test statistic p-value
Delivery mode
Vaginal delivery 75.5 (799) 83.3 (50) 81.4 (381) 72.7 (131) 67.7 (237)
X2 = 23.03 < 0.001*
Caesarean section 24.5 (259) 16.7 (10) 18.6 (87) 27.3 (49) 32.3 (113)
Maternal hospital stay
≤ 1 day 21.7 (230) 16.7 (10) 23.3 (109) 23.9 (43) 19.4 (68)
X2 = 15.06 0.022*1 day 31.6 (334) 38.3 (23) 37.2 (174) 28.3 (51) 24.6 (86)
≥1 day 46.7 (494) 45 (27) 39.5 (185) 47.8 (86) 56 (196)
Baby staying for over 24 hours in the  hospital
No 42.7 (452) 41.6 (25) 48.5 (227) 42.8 (77) 35.1 (123)
X2 = 7.46 0.024*
Yes 57.3 (606) 58.4 (35) 51.5 (241) 57.2 (103) 64.9 (227)
Babies staying for 
over 24 hours in the 
hospital: duration
52.3 (606) 5.8 (35 of 606) 39.8 (241 of 606) 16.9 (103 of 606) 37.5 (227 of 606)
≤ 3 days 47.7 (289)** 62.9 (22) 51.5 (124) 47.6 (49) 41.4 (94)
F5,11 = 18.63
*** 0.001*≥ 3 days, ≤ 2 weeks 45.7 (277)** 34.3 (12) 41.1 (99) 45.6 (47) 52.4 (119)
≥ 2 weeks 6.6 (40)** 2.8  (1) 7.4 (18) 6.8 (7) 6.2 (14) 
Gestational period
Preterm 28.7 (304) 36.6 (22) 28.6 (134) 28.9 (52) 27.4 (96)
X2 = 5.43 0.487Term 56.6 (598) 51.7 (31) 58.2 (272) 57.2 (103) 54.9 (192)
Post-term 14.7 (156) 11.7 (7) 13.2 (62) 13.9 (25) 17.7 (62)
Mean current birthweight (2-7 days after birth) = 3.6 kg (± 0.74)
Birthweight z-scores
Below - 2 SD 7.1 (75)** 16.7 (10) 7.5 (35) 6.1 (11) 5.4 (19)
F5,11 = 10.40 0.006
*≥ - 2 SD, ≤ + 2 SD 90.5 (958)** 81.7 (49) 89.9 (421) 92.7 (167) 91.7 (321)
Above + 2 SD 2.4 (22)** 1.6 (1) 2.6 (9) 1.2 (2) 2.9 (10)
Mean length (2-7 days after birth) = 51.2 cm (± 3.12)
Birth length z-scores
Below - 2 SD 12.6 (134)** 23.3 (14) 12.8 (60) 11.7 (21) 11.1 (39)
F5,11 = 9.89 0.007
*≥ - 2 SD, ≤ + 2 SD 82.1 (869)** 70 (42) 83.5 (391) 83.9 (151) 81.4 (285)
Above + 2 SD 5.3 (52)** 6.7 (4) 3.7 (14) 4.4 (8) 7.5 (26)
Mean HC (2-7 days after birth) = 35.7 cm (± 2.01)
Birth HC z-score
Below -2 SD 7.3 (77)** 18.3 (11) 7.7 (36) 4.4 (8) 6.3 (22)
F5,11 = 9.01 0.007*≥-2 sd, ≤+2sd 80.2 (849)** 73.3 (44) 82.7 (387) 84.4 (152) 76 (266)
Above +2sd 12.5 (129)** 8.4 (5) 9.6 (42) 11.2 (20) 17.7 (62)
Low birthweight ≤ 2 500 g
No 96.6 (1 022) 96.7 (58) 96.8 (453) 93.3 (170) 97.4 (341)
F4,7 = 7.08 0.07Yes 3.4 (36) 3.3 (2) 3.2 (15) 6.7 (10) 2.6 (9)
Macrosomic ≥ 4 500 g
No 91.5 (968) 90 (54) 91.5 (428) 93.3 (168) 90.9 (318)
X2 = 1.138 0.768
Yes 8.5 (90) 10 (6) 8.5 (40) 6.7 (12) 9.1 (32)
Gestational diabetes
No 97.8 (1028)**** 100 (60) 97.4 (456) 97.8 (176) 96 (336)
F4,7 = 9.44 0.048
*
Yes 2.8 (30)**** 0 (0) 2.6 (12) 2.2 (4) 4 (14)
Pregnancy-induced hypertension
No 82.4 (872) 83.3 (50) 87.2 (408) 81.1 (146) 76.6 (268)
X2 = 15.83 0.001*
Yes 17.6 (186) 16.7 (10) 12.8 (60) 18.9 (34) 23.4 (82)
F: Manova test statistic, HC: head circumference, SD: standard deviation, X2 = chi-square test statistic
*: p-value < 0.05 
**: Significant difference between groups < - 2 standard deviation and > - 2 standard deviation and < + 2 standard deviation and groups > - 2 standard deviation and < + 2 standard deviation and > = 2 standard 
deviation
***: Significant difference between underweight and normal gestational body mass index categories and underweight and obese gestational BMI categories
****: Significant difference between developing gestational diabetes mellitus and not developing gestational diabetes mellitus
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consume the majority of the healthcare resources, compared to 
primary and preventative clinics.23 Approximate costs of hospital 
stay per day without drugs and diagnostic testing vary between 
clinics and hospitals (primary clinic: US$60.89, secondary hospital: 
US$79.44 and a tertiary hospital: US$108.51).24 Olukoga23 reported 
that the unit cost per day in district South African hospitals was 
highest for maternal inpatients.23 Women who were identified as 
being in the obese gestational BMI category should be allocated more 
antenatal clinic appointments. This would potentially decrease the 
risk of them (and their babies) staying longer in hospital postnatally, 
which would also have a positive impact on the economic cost of the 
health service.25
This study showed a significant difference between the z-score 
categories and birth and post-birth anthropometry. Significant 
differences were also found between gestational BMI categories. 
These findings agree with those of other considerably larger studies 
that have found gestational BMI to be positively associated with 
birthweight, length and HC.23,24,26-28 One of these studies also found 
that  women who were classified in the low gestational BMI group 
had a higher risk of delivering preterm, and an increase in neonatal 
mortality, whereas those in this study did not.29 This could be 
because of the fact that only 5.7% of the women in our study were 
in the underweight gestational BMI category.  
Studies indicate that women with a lower30 and higher26-28 pregravid 
BMI are more at risk of giving birth to a low birthweight baby. There 
was a relatively low percentage (3.4%) of low birthweight babies in 
the present study, compared to the rates (9.7-29.2%) in the most 
recent Saving babies report (2010-2011).31 However, the z-score 
was calculated for this particular cohort. The mean birthweight of 
the cohort was 3.6 kg, which is higher than the average birthweight 
of infants of black African ethnic origin (3.1 kg).32,33 Therefore, 
the SDs would be shifted to the right. Another factor to take into 
consideration is the fact that the Saving babies report is an audit 
for the whole of South Africa, which includes different population 
groups and different geographical locations. This lower rate could 
also be owing to the low percentage (5.7%, 60 of 1 058) of women 
in the underweight gestational BMI category. Women who had given 
birth prematurely were missed during recruitment and no data for 
women under 18 years of age were obtained. Babies from teenage 
pregnancies are at a higher risk of low birthweight.34 There was also 
a low prevalence of smokers in the cohort (3.6%). Smoking may 
inhibit maternal weight gain and is a risk factor for low birthweight 
babies.
In this study, there was a relatively higher percentage (8.5%) of 
macrosomic babies compared to that in other South African studies 
(2.3-3.43%) which focused on the black African population.35,36 
There are various risk factors for macrosomia, the strongest being 
gestational diabetes mellitus, followed by high gestational BMI.35-37 
The later could be the reason for the higher macrosomic incidence 
in this substudy. However, no significant difference was found 
between the gestational BMI categories and macrosomia. Mothers 
who develop gestational diabetes mellitus have an increased risk of 
developing type 2 diabetes mellitus, and infants born to mothers who 
have gestational diabetes mellitus are at an increased risk of adverse 
birth outcomes, including macrosomia and childhood obesity.38-40 A 
reason for the low prevalence of gestational diabetes mellitus could 
be the low mean age (26.3 ± 5.4 years) of the women in this study, 
which is comparable with that of the women in a study by Mamabola 
et al.41 The highest proportion of women who developed gestational 
diabetes mellitus were categorised in the obesity group. This is in 
agreement with the findings of Mamabola et al,41 who also reported 
that women who developed gestational diabetes mellitus were 
significantly heavier than those who did not.41
The prevalence of hypertension is increasing in South African women 
(25%) alongside the increase in  obesity.42 Approximately 16% of 
maternal deaths were due to complications of pregnancy-induced 
hypertension.43 In the present study, more than twice as many 
women (17.6%) had pregnancy-induced hypertension, than those 
in another South African study.43 This could possibly be explained 
by the fact that the other study used women from both urban and 
rural regions, whereas this study’s participants’ diet and weight were 
influenced by urbanisation.43 Black South Africans are particularly at 
risk because of a genetic susceptibility to low-renin, low-aldosterone 
hypertension.44 In agreement with others,45-47 this study found that 
significantly more women in the obese gestational BMI category 
developed pregnancy-induced hypertension.47-49 If the women have 
been placed in a high-risk category, more observation, monitoring 
and appropriate intervention should take place.45 Pregnancy-induced 
hypertension is frequently exposed by pregnancy and the mother 
often develops hypertension later in life.  
Weight (97%) and height (90.4%) were recorded in the majority of 
antenatal clinics in the Western Cape.5 With appropriate training 
and calibrated equipment, the gestational BMI method is simple to 
determine using a calculator, and can be used to identify women at 
high risk during pregnancy and labour.
Limitations to the study
The participants were not informed of the distinction between 
pregnancy-inducted hypertension and pre-eclampsia. Therefore, 
the two different morbidities could not be separated in the analysis. 
Most of the women were recruited in their third trimester, so women 
who gave birth prematurely could have been missed. No participants 
under the age of 18 were included in the study. Teenage pregnancies 
are at higher risk of the following adverse birth outcomes: low 
birthweight, premature infants, and those with a smaller length and 
HC.34 There was intervariable reliability as infant anthropometric 
measurements (birthweight, length and HC) were obtained from the 
clinic card and post-birthweight, length and HC and maternal weight 
and height were measured by trained data collectors. Most of the 
information was obtained from participants’ memory recollection, so 
accuracy of recall was a potential limitation. No significant difference 
was found between the gestational period and the gestational BMI 
categories. The gestational period in the substudy was questionable 
as it was calculated based on the last menstrual cycle.  
Conclusion
To the best of our knowledge, this is the first study that has used 
the gestational BMI method in a peri-urban South African pregnant 
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population. Based on findings, it is recommended that the gestational 
BMI one-off method is implemented as a pilot study in a selection 
of rural, peri-urban and urban primary health clinics, and that the 
simplicity and effectiveness thereof is evaluated as a screening 
tool. The gestational BMI method could be a useful and practical 
tool with which to identify high-risk pregnancies. With appropriate 
training, it is relatively easy to use. Appropriate medical and optimal 
nutrition advice could then be given to pregnant women antenatally 
and postnatally to improve birth-related outcomes and maternal 
morbidities. Gestational BMI could identify women who need to be 
referred for hospital delivery as their chances of having to undergo a 
Caesarean section would be higher.
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